Caxton Associates (UK)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Buy
71,099
+11,099
+18% +$3.07M 0.29% 30
2026
Q1
$17.7M Hold
60,000
0.4% 30
2025
Q4
$16.4M Hold
60,000
0.32% 39
2025
Q3
$16.2M Sell
60,000
-89
-0.1% -$24.2K 0.38% 27
2025
Q2
$16.6M Buy
60,089
+89
+0.1% +$24.2K 0.42% 33
2025
Q1
$15.9M Buy
+60,000
New +$14.8M 0.55% 25

Other funds holding CME

Caxton Associates (UK)'s CME Position: Q2 2026 in Review

Caxton Associates (UK) increased its CME Group (CME) stake by 18% in Q2 2026, buying an estimated $3.07M and bringing the position to 71,099 shares worth $15.7M. The position accounts for 0.29% of the portfolio, ranked #30.

Caxton Associates (UK) first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.7M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Caxton Associates (UK) held 71,099 shares of CME Group worth $15.7M as of Q2 2026.
  • Caxton Associates (UK) bought 11,099 CME Group shares in Q2 2026, an estimated $3.07M.
  • CME Group made up 0.29% of Caxton Associates (UK)'s portfolio in Q2 2026, its #30 holding.
  • Caxton Associates (UK) first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s CME Group position peaked at $17.7M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.